A high-throughput molecular data resource for cutaneous neurofibromas
Citations Over TimeTop 10% of 2017 papers
Abstract
Neurofibromatosis type 1 (NF1) is a genetic disorder with a range of clinical manifestations such as widespread growth of benign tumours called neurofibromas, pain, learning disorders, bone deformities, vascular abnormalities and even malignant tumours. With the establishment of the Children's Tumour Foundation biobank, neurofibroma samples can now be collected directly from patients to be analysed by the larger scientific community. This work describes a pilot study to characterize one class of neurofibroma, cutaneous neurofibromas, by molecularly profiling of ~40 cutaneous neurofibromas collected from 11 individual patients. Data collected from each tumour includes (1) SNP Arrays, (2) Whole genome sequencing (WGS) and (3) RNA-Sequencing. These data are now freely available for further analysis at http://www.synapse.org/cutaneousNF.
Related Papers
- → Neurofibroma of the Larynx in Neurofibromatosis(2001)25 cited
- → Incidental Finding of Isolated Colonic Neurofibroma(2013)10 cited
- → Hypervascular neurofibromas in a case of neurofibromatosis type 1 - a case report(2011)1 cited
- Expression of neurofibromin and Ras-p21 protein in neurofibromas tissue from neurofibromatosis type 1 patients(2008)
- → Different Pathology of Peripheral Nerve Sheath Tumor in Neurofibromatosis Type 1: 3 Cases(2021)